How has the pandemic impacted innovation in clinical trials?

“In a time where COVID-19 has taken its toll across many sectors and industries, including the clinical trial industry, the need for rethinking the way clinical trials can be conducted has become increasingly clear!” says Anders Daniel Andersen, Head of Medical Sciences & Safety at Studies&Me, a LEO Innovation Lab spin out, when asked about

How has the pandemic impacted innovation in the health tech industry?

The pandemic has changed the world. All people, countries and industries have been affected one way or another. With challenges comes opportunities, and for our industry change is often welcomed as change is more often than not followed closely by innovative solutions and meaningful change.  Andrei Chiriac, Omhu According to Andrei Chiriac, Senior Medical Advisor

COVID-19 spurs the need for remote assessments in clinical research

In a time where social distancing has become the norm, the clinical trial industry may be forced to rethink operational aspects. Here’s how LEO Innovation Lab in cooperation with LEO Medical Sciences, Bispebjerg Hospital — Denmark and Stanford — USA have co-developed remote efficacy measures using patients’ own smartphones. Mette Brøgger-Mikkelsen, Medical Associate, LEO Innovation Lab Since the COVID-19

Innovating for Social Good

When we think of capital, financial capital is what often comes to mind although natural, human, intellectual, and digital capital are essential elements for societies, businesses, and economies. This year’s St. Gallen Symposium challenged leaders of today and tomorrow worldwide to look past financial capital and find purpose beyond profit. Director of Entrepreneurship & Innovation,